Recordati Will Adopt Orphan Europe For $191 Million
This article was originally published in The Pink Sheet Daily
Italian firm, which has mainly focused on primary care, anticipates deal will help establish its presence in the growing European specialty pharma market.
You may also be interested in...
Second Phase III pivotal study backs fewer-dose benefit
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.